Studies & Therapeutic Areas
Support shaped by the study—not a fixed package.
Veratryx supports biometrics work across clinical development for biotechnology, pharmaceutical, CRO and clinical-research organizations.
01
Across clinical development
Phase I–IV support across early-phase, confirmatory and post-approval programs, aligned to the protocol, milestones and sponsor requirements.
Phase I–IVEarly phase through post-approval
Study-specificScope follows protocol and milestones
02
Study designs
- Randomized and blinded trials
- Double-blind and open-label designs
- Interventional studies
- Observational programs
03
Therapeutic focus
- Oncology
- Neuroscience
- Immunology
- Other sponsor-defined programs where the assigned specialists have relevant capability
Therapeutic scope is confirmed against the experience of the specialists assigned to each engagement.
Next step